0.9% Sodium Chloride Injection USP recall: Particulate Matter
0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.
Why was 0.9% Sodium Chloride Injection USP recalled?
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: a) P309187, Exp 10/14; b) P298190, Exp 08/14
- Product
- 0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.
- Recalling firm
- Baxter Healthcare Corp.
- Quantity
- a) 217,536 bags; b) 161,760 bags
- Distribution
- Nationwide, Puerto Rico, Singapore, and Hong Kong
- Recall date
- September 24, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)